View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

National Cancer Institute and Merck Research Labs Guests on Pharma Talk Radio Discussing the Exciting Potential and Challenges with Immuno-Oncology


  • June 5, 2015

  • Immuno-Oncology is arguably the most exciting area in the advancement of science and patient care today.  However, with all research, there are plenty of challenges and to get a better understanding of this innovative approach to cancer research, we were pleased to welcome to Pharma Talk Radio, James Gulley, MD, PhD of the National Cancer Institute and Roy Baynes, MD, PhD at Merck Research Labs. Joining Drs Gulley and Baynes was Kate Woda, Director of the IO360 conference taking place at Columbia University Faculty House on June 29-30 in NYC.

    Valerie Bowling, Conference Director, CMOW SummitHost:
    Valerie Bowling, Producer, Pharma Talk Radio

     

     

    Guests:
    James Gulley BWJames Gulley, MD, PhD, Head, Immunotherapy Section, Director, Medical Oncology Service, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute

     

    Roy Baynes B&WRoy Baynes, MD, PhD, Senior Vice President, Global Clinical Development, Merck Research Labs

     

     

    Kate Woda B&WKate Woda, Director, IO 360

     

     

     

    Listen to the Episode: http://www.blogtalkradio.com/pharmatalk/2015/06/04/immuno-oncology-exploring-the-challenges-potential

    For more details on Immuno-Oncology 360 visit: http://theconferenceforum.org/conferences/immuno-oncology-360/overview/